{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Angiogenesis > Lenvatinib MesylateCAS：857890-39-2
Molecular Formula：C22H23ClN4O7S
Molecular Weight：522.96
Storage：Powder:2-8℃，2 years
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 857890-39-2 |
| Name | Lenvatinib Mesylate |
| Molecular Formula | C22H23ClN4O7S |
| Molecular Weight | 522.96 |
| Solubility | Soluble in DMSO ≥0.5mg/mL(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years |
| EC | EINECS 812-398-0 |
| MDL | MFCD18633219 |
| SMILES | COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O |
| InChIKey | HWLFIUUAYLEFCT-UHFFFAOYSA-N |
| InChI | InChI=1S/C21H19ClN4O4.CH4O3S/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11;1-5(2，3)4/h4-11H，2-3H2，1H3，(H2，23，27)(H2，25，26，28);1H3，(H，2，3，4) |
| PubChem CID | 11237762 |
| Target Point | VEGFR;FGFR;PDGFR;RET;c-Kit |
| Passage | Angiogenesis;Protein Tyrosine Kinase/RTK |
| Background | It is a multi-target tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet-derived growth factor receptor (PDGFR), stem cell factor receptor (KIT), and rearrangement during transfection (RET). |
| Unit | Bottle |
| Specification | 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
